Literature DB >> 20717936

Exhaled air temperature in children with bronchopulmonary dysplasia.

Silvia Carraro1, Giorgio Piacentini, Marta Lusiani, Zeynep S Uyan, Marco Filippone, Maurizio Schiavon, Attilio L Boner, Eugenio Baraldi.   

Abstract

BACKGROUND: Because they have similar functional and clinical profiles, bronchopulmonary dysplasia (BPD) survivors are often treated as asthmatic patients. In truth, very little is known about the possible biochemical and inflammatory mechanisms playing a part in BPD survivors' lungs. The aim of this study was to measure exhaled breath temperature in BPD survivors by comparison with asthmatic cases and healthy controls.
METHODS: Three groups of age-matched adolescents (n = 17 each), that is, BPD survivors (gestational ages <31 weeks, birth weights <1,500 g), asthmatic subjects and healthy controls, underwent exhaled breath temperature and exhaled nitric oxide measurements, and spirometry.
RESULTS: Exhaled breath temperature was significantly lower in the BPD survivors (26.72°C [25.11-27.57]) than in the asthmatic patients (29.60°C [29.20-30.02], P < 0.001), while no significant difference emerged by comparison with healthy controls (26.97°C [26.58-27.38]). Considering the whole study population, a significant correlation was found between exhaled breath temperatures and exhaled nitric oxide concentrations (R = 0.42, P = 0.004). Spirometry revealed an obstructive lung function pattern in both the asthmatic cases and the BPD survivors, with lower parameters in the latter.
CONCLUSIONS: Exhaled breath temperatures and exhaled nitric oxide concentrations are significantly lower in BPD survivors than in asthmatic cases, suggesting that different pathogenetic mechanisms characterize these two chronic obstructive lung diseases.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20717936     DOI: 10.1002/ppul.21317

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  6 in total

1.  Exhaled breath temperature in NSCLC: could be a new non-invasive marker?

Authors:  Giovanna E Carpagnano; Donato Lacedonia; Antonio Spanevello; Domenico Martinelli; Valerio Saliani; Cinzia Ruggieri; Maria P Foschino-Barbaro
Journal:  Med Oncol       Date:  2014-04-11       Impact factor: 3.064

Review 2.  Lifelong Lung Sequelae of Prematurity.

Authors:  Paola Di Filippo; Giulia Dodi; Francesca Ciarelli; Sabrina Di Pillo; Francesco Chiarelli; Marina Attanasi
Journal:  Int J Environ Res Public Health       Date:  2022-04-26       Impact factor: 4.614

3.  Repeated β2-adrenergic receptor agonist therapy attenuates the response to rescue bronchodilation in a hyperoxic newborn mouse model.

Authors:  Thomas Raffay; Prabha Kc; James Reynolds; Juliann Di Fiore; Peter MacFarlane; Richard J Martin
Journal:  Neonatology       Date:  2014-06-20       Impact factor: 4.035

Review 4.  Addressing the risk domain in the long-term management of pediatric asthma.

Authors:  Eckard Hamelmann; Erika von Mutius; Andrew Bush; Stanley J Szefler
Journal:  Pediatr Allergy Immunol       Date:  2019-12-11       Impact factor: 6.377

Review 5.  Challenging the paradigm: moving from umbrella labels to treatable traits in airway disease.

Authors:  Andrew Bush; Ian D Pavord
Journal:  Breathe (Sheff)       Date:  2021-09

6.  Application of nitric oxide measurements in clinical conditions beyond asthma.

Authors:  Andrei Malinovschi; Dora Ludviksdottir; Ellen Tufvesson; Giovanni Rolla; Leif Bjermer; Kjell Alving; Zuzana Diamant
Journal:  Eur Clin Respir J       Date:  2015-08-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.